Centene initiated with an Outperform at Cowen. Cowen analyst Charles Rhyee initiated Centene with an Outperform rating as he likes its leading position in Medicaid and the individual exchanges, which he views as complementary businesses. He noted the strong track record in winning new business in Medicaid and in high acuity populations. Rhyee has a $77 price target on Centene shares.
https://thefly.com/landingPageNews.php?id=2872211
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.